Deprecated: Required parameter $field follows optional parameter $value in /customers/6/e/3/senatormedical.se/httpd.www/wp-content/plugins/stm-gdpr-compliance/includes/plugins/GravityForms.php on line 142 Warning: Cannot modify header information - headers already sent by (output started at /customers/6/e/3/senatormedical.se/httpd.www/wp-content/plugins/stm-gdpr-compliance/includes/plugins/GravityForms.php:142) in /customers/6/e/3/senatormedical.se/httpd.www/wp-includes/feed-rss2.php on line 8 breast cancer surgery – Senator Medical AB https://www.senatormedical.se Strategic partner in Healthcare business Wed, 11 Dec 2019 08:55:11 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://www.senatormedical.se/wp-content/uploads/2018/11/cropped-Senator-Logo.jpg breast cancer surgery – Senator Medical AB https://www.senatormedical.se 32 32 60550935 Focus shift: Breast Cancer from treatment to prevention https://www.senatormedical.se/breast-cancer-prevention-comes-to-focus-instead-of-treatment-oncology-article-senator-medical-ab-stockholm-sweden/ https://www.senatormedical.se/breast-cancer-prevention-comes-to-focus-instead-of-treatment-oncology-article-senator-medical-ab-stockholm-sweden/#respond Wed, 11 Dec 2019 08:55:00 +0000 https://www.senatormedical.se/?p=2018 If protective measures were widely adopted, they could significantly reduce women’s chances of ever getting breast cancer.

Efforts to reduce deaths from breast cancer in women have long focused on early detection and post-surgical treatment with drugs, radiation or both to help keep the disease at bay. And both of these approaches, used alone or together, have resulted in a dramatic reduction in breast cancer mortality in recent decades.

The average five-year survival rate is now 90 percent, and even higher — 99 percent — if the cancer is confined to the breast, or 85 percent if it has spread to regional lymph nodes.

Yet, even though a steadily growing percentage of women now survive breast cancer, the disease still frightens many women and their loved ones. It affects one woman in eight and remains their second leading cancer killer, facts that suggest at least equal time should be given to what could be an even more effective strategy:

Prevention

Long-term studies involving tens of thousands of women have highlighted many protective measures that, if widely adopted, could significantly reduce women’s chances of ever getting breast cancer. Even the techniques now used to screen for possible breast cancer can help identify those women who might be singled out for special protective measures.

Reference & entire original article at The New York Times 

]]>
https://www.senatormedical.se/breast-cancer-prevention-comes-to-focus-instead-of-treatment-oncology-article-senator-medical-ab-stockholm-sweden/feed/ 0 2018
Importance of Body image for women (Breast Cancer Article) https://www.senatormedical.se/importance-of-body-image-for-women-breast-cancer-article-dignicap-senator-medical-ab/ https://www.senatormedical.se/importance-of-body-image-for-women-breast-cancer-article-dignicap-senator-medical-ab/#respond Mon, 19 Aug 2019 12:23:05 +0000 https://www.senatormedical.se/?p=1923 Body image in women with breast cancer using a scalp cooling system to reduce chemotherapy induced hair-loss

Background: Most women consider hair to be an important part of body image. Alopecia is an emotionally traumatic side effect for breast cancer patients undergoing adjuvant chemotherapy. The DigniCap™ Scalp Cooling System is the first scalp cooling system cleared by the US Food and Drug Administration to reduce the likelihood of chemotherapy induced alopecia.

Methods: Quality of Life (QOL) data were collected as part of a prospective clinical trial evaluating the clinical performance of scalp cooling in women with early stage BC receiving adjuvant chemotherapy.

The study’s primary endpoint was hair loss as evaluated by patient self-assessment. Treatment success was defined as ≤ 50% hair loss. QOL was evaluated by the EORTC-QLQ-BR23 (BR23) administered at baseline, last chemotherapy cycle, and one month later. For BR23, 4 response categories were collapsed to 2 categories (Not at all/A little bit and Quite a bit/Very much) for analysis. QOL was compared between those with success vs. failure of scalp cooling.

Results: 101 patients were evaluable for the primary endpoint: Success was seen in 67 (66.3%) pts. QOL at study entry was comparable between pts with scalp cooling success or failure for each item in the BR23 questionnaire. Results reported as percentages of patients in each group who answered either quite a bit or very much to body image-related questions on the BR23 questionnaire are displayed in Table 1.

Reference: Cancer Research Journal

]]>
https://www.senatormedical.se/importance-of-body-image-for-women-breast-cancer-article-dignicap-senator-medical-ab/feed/ 0 1923
Role and duties of a surgical oncologist https://www.senatormedical.se/know-more-about-your-cancer-doctors-who-is-surgical-oncologist-doctor-and-what-he-actually-does/ https://www.senatormedical.se/know-more-about-your-cancer-doctors-who-is-surgical-oncologist-doctor-and-what-he-actually-does/#respond Fri, 09 Aug 2019 10:16:29 +0000 https://www.senatormedical.se/?p=1774 History of Surgical Oncology

Surgical oncology, as a specialised method of surgery for cancerous tumours, has evolved since the last three decades. Surgery is usually considered to be the most effective method of treatment of cancer. Ephraim McDowell undertook the first reported cancer surgery for ovarian tumour in 1809.

Who is a Surgical Oncologist?

Surgical oncologists specialise in the treatment of malignant neoplastic disease, with in-depth knowledge and expertise to perform the standard and advanced procedures as considered necessary for each patient. An accomplished surgical oncologist not only possesses the ability to diagnose tumours but has adequate knowledge in haematology, pathology, medical oncology and radiation oncology. Surgical oncologists, when considered necessary, refer patients to radio therapists for tests, and ensure appropriate multimodality care. This, in turn, aids in undertaking the accurate line of treatment. Over the past 30 years, Dr. Amish Dalal has successfully diagnosed and treated patients with cancer.

Multidisciplinary Management of Cancer

As discussed above, surgical oncologists referring patients to radio oncologists denote the multidisciplinary management of the treatment. Solid malignancies can be treated successfully simply through therapy alone, when detected during the early stage. However, in addition to standard therapy treatment, surgeries are indicated in advanced stages. This supports the argument that surgery is usually opted as an effective method in the treatment of cancer. Dr Amish V Dalal, a Surgical Oncologist, is renowned for his expertise in conducting cancer surgeries.

An Overview of the Role of a Surgical Oncologist

The role of a surgical oncologist primarily spans over four areas:

  • Exploring the scope of effective treatment solely through therapy, especially in early stages, which may avoid the need of a resection (removal of a tumour through surgery)
  • Excision of malignant tumours
  • Removal of malignant lymph nodes at the time of surgery
  • Treating any cases of recurrence of the disease

A study of the complete history of a patient and physical examination during consultation helps the surgical oncologist to assess the medical condition of the patient and decide upon the line of treatment, that is, whether it is treatable through therapy alone, or it warrants resection. If managed through surgery, a combination of post-surgical treatment including radiotherapy and chemotherapy is generally followed.

An acclaimed surgical oncologist is adept with removing cancer tumours and a portion of surrounding tissue, which may not look infected macroscopically but carries the risk of being malignant, which may be detected microscopically. This procedure usually helps in preventing the disease from spreading to other parts of the body and recurring in the future. In the case of borderline resection, the oncologist conducts a surgery, referred to as ‘Debulking’, to remove as much tumour as is considered possible and follow-up with post-surgery therapy to relieve pain. Amish Dalal, a renowned Oncologist, is proficient with conducting gynaecological oncological surgeries, after analysing the nature, location and stage of tumours.

Methods of Surgery

The method of surgery followed by the surgical oncologist depends on the location and stage of the disease, as well as other factors including health condition and fitness of the patient. Doctor Amish Dalal has the necessary expertise in the following methods of cancer surgery:

  1. Open Surgery
  2. Laparoscopy, depending on the patient’s medical condition and financial resources
  3. Robotic Surgery

Doctor Amish Dalal, with his knowledge in his field of specialisation and along with the state-of-the-art surgical equipments, is able to provide world-class management of the disease. Dr. Amish Vasant Dalalalso conducts Robotic Surgery – one of the most advanced surgical methods in the field of medical science. The surgery provides the surgeon the advantage of 10x magnification along with a 3D view while operating. This method of surgery not only reduces pain considerably but also ensures speedy recovery as compared to Open Surgery.

Role Of A Surgical Oncologist Post-Surgery: Reconstructive Surgery

Many patients, in cases where oncological surgery may have had a disfigurative impact on body aesthetics, may opt for a reconstructive surgery. Reconstruction that follows close to the heels of the oncological surgery is known as ‘Immediate Reconstruction’. Reconstructive Surgery can also be undertaken a few weeks or months later, and is referred to as ‘Delayed Reconstruction’. In such cases, the patient is referred to a plastic surgeon for ‘Oncoplastic Surgery’.

Read more on article here

]]>
https://www.senatormedical.se/know-more-about-your-cancer-doctors-who-is-surgical-oncologist-doctor-and-what-he-actually-does/feed/ 0 1774
Epidemiology of Breast Cancer in Young Women in the Southern part of the Mediterranean Area https://www.senatormedical.se/breast-cancer-in-sub-mediterranean-territories/ https://www.senatormedical.se/breast-cancer-in-sub-mediterranean-territories/#respond Mon, 05 Aug 2019 12:56:42 +0000 https://www.senatormedical.se/?p=1873

Breast Cancer Article-June 2017

Abstract: In Northern Africa, the high incidence of breast cancer among young women has been recognized as a particular epidemiologic feature within the region. However, a comprehensive epidemiological overview of the existing data is lacking.

Within this present review we aim to: (i) asses the available and reliable epidemiologic data reported from institutional series and registries (ii) investigate the possible impact of demographic or genetic factors on epidemiology and (iii) describe the distinct risk factors and tumour biology of breast cancer in young women presenting in this region of the world.

The evolution of young breast cancer incidence around the Mediterranean area and particularly in the region of Northern Africa will be discussed, as well as it is association to the existing demographic context. The issue of possible bias likely to influence the reported incidence rates, as obtained from the regional registries, will be elucidated. We will finally underline that interpretation of data coming from these registries should be cautious, as the concentration of resources within some metropolitan centres (or regions) may induce bias in terms of patients’ reporting.

Reference Article

Keywords: Breast cancer, Young women, Cancer registry, Epidemiology, Mediterranean area.

 
]]>
https://www.senatormedical.se/breast-cancer-in-sub-mediterranean-territories/feed/ 0 1873
What is “Surgical Oncology”? https://www.senatormedical.se/what-is-surgical-oncology/ https://www.senatormedical.se/what-is-surgical-oncology/#respond Wed, 05 Jun 2019 12:13:27 +0000 https://www.senatormedical.se/?p=1762 Surgical oncology is the medical specialty that is concerned with the surgical treatment and removal of tumors. In fact, surgery is one of the oldest means of treating cancer. Ancient Egyptians in the 7th century meticulously described techniques for the removal of tumors of the breasts. Thanks to recent advances in terms of the safety and efficacy of anesthesia, surgery, in general, has been rapidly evolving.

The specialists responsible for carrying out these procedures are called surgical oncologists and are typically general surgeons who underwent additional training in the management of oncological patients. Thus, they do not commence their training until after approximately 5 – 7 years of training in general surgery.

Surgical oncologists often form part of a multi-disciplinary team and provide valuable insight to this group of professionals. Surgical oncologists may share their expertise with regard to the techniques necessary for biopsies, the resectability of the cancers and the role of surgery, if it is necessary.

Surgical Oncologist definition- Senator Medical AB, Stockholm, Sweden

They may subspecialize in varying body regions, to limit their focus to particular types of cancers. This approach allows for optimal management with regards to the diagnosis and treatment as well as the prevention of those cancers.

There is often collaboration with geneticists, pathologists, radiologists and medical oncologists. Geneticists are vital for giving insights into the screening strategies and/ or prevention of hereditary cancers. Like other members of the multi-disciplinary team, they also optimize the treatment possibilities.

Collaboration with pathologists is necessary for ensuring the quality assurance of the surgery and the need for additional therapies based on mutational and/ or tumor immuno-phenotyping. Radiologists and medical oncologists assist with the planning of the surgery and ensure that applicable therapies are used when they are indicated.

Techniques

Surgical oncologists not only remove cancerous lesions, but some of the surrounding tissue at the site of the lesions as well. This is a preventative means against local recurrence of the tumor. It is known as a clear margin incision. In some instances, however, it is not possible to completely remove the tumor.

Therefore, parts of it are removed in order to alleviate the symptoms that the mass effect of the tumor produces. This technique is referred to as debulking. Symptoms of mass effect include pain, bleeding, obstruction of the airway, or nerve disturbances due to compression.

It is crucial that the surgical oncologist is skilled in removal of the tumor for quality assurance. This is particularly important, because adjuvant radio- and chemotherapy may not compensate for surgeries that have been inadequately or poorly conducted.

Moreover, the draining lymph nodes of the tissue involved may also be surgically removed. This depends on the type of cancer and its spread. In cases where there is spreading of the cancer, chemo- and/ or radiotherapy is necessary. Lymph node involvement may not be a favorable prognostic sign as this may be an indication that the cancer has had the chance to metastasize.

References

http://www.essoweb.org/what-is-surgical-oncology/

https://www.oncolink.org/cancer-treatment/surgery/overview/surgical-oncology-the-basics

]]>
https://www.senatormedical.se/what-is-surgical-oncology/feed/ 0 1762